BBIO
BridgeBio Pharma·NASDAQ
--
--(--)
--
--(--)
5.62 / 10
Netural
Technical assessment reveals 5.62/10 overall, depicting mixed technical signals. Constructive developments in Bearish Engulfing and MACD Death Cross are mitigated by adverse signals in MACD Golden Cross and Long Lower Shadow. Technical forecast: neutral with watchful bias.
Analysis Checks(2/4)
Long Lower Shadow
Score3.81/10
Win Rate50.00%
Hist. Signals14
Avg Return0.55%
Score3.81/10
Win Rate50.00%
Hist. Signals14
Avg Return0.55%
MACD Death Cross
Score7.41/10
Win Rate63.64%
Hist. Signals11
Avg Return2.98%
Score7.41/10
Win Rate63.64%
Hist. Signals11
Avg Return2.98%
Bearish Engulfing
Score8.1/10
Win Rate71.43%
Hist. Signals7
Avg Return1.74%
Score8.1/10
Win Rate71.43%
Hist. Signals7
Avg Return1.74%
MACD Golden Cross
Score3.18/10
Win Rate45.45%
Hist. Signals11
Avg Return0.45%
Score3.18/10
Win Rate45.45%
Hist. Signals11
Avg Return0.45%
Long Lower Shadow
Score3.81/10
Win Rate50.00%
Hist. Signals14
Avg Return0.55%
Score3.81/10
Win Rate50.00%
Hist. Signals14
Avg Return0.55%
Bearish Engulfing
Score8.1/10
Win Rate71.43%
Hist. Signals7
Avg Return1.74%
Score8.1/10
Win Rate71.43%
Hist. Signals7
Avg Return1.74%
MACD Death Cross
Score7.41/10
Win Rate63.64%
Hist. Signals11
Avg Return2.98%
Score7.41/10
Win Rate63.64%
Hist. Signals11
Avg Return2.98%
MACD Golden Cross
Score3.18/10
Win Rate45.45%
Hist. Signals11
Avg Return0.45%
Score3.18/10
Win Rate45.45%
Hist. Signals11
Avg Return0.45%
What is the current technical signals for BBIO?
- BBIO presents a Netural setup with a Technical Score of 5.62/10. Key technical indicators highlight an RSI of 37.07 and a MACD of -2.81, with the trend anchored by the 50-Day SMA at 75.19. Traders should monitor key support at 59.07 and resistance at 72.15.
